Introduction
The Point Of Care Diagnostics Market size is estimated at USD 53.63 billion in 2025, and is expected to reach USD 84.93 billion by 2030, at a CAGR of 9.63% during the forecast period (2025-2030). The market’s growth is fueled by the increasing need for rapid, near-patient diagnostic testing that reduces time-to-treatment and lowers overall healthcare costs. Point of care diagnostics are increasingly adopted across hospitals, clinics, and home-care settings, with North America being the largest market and Asia-Pacific the fastest-growing region. Factors such as rising prevalence of chronic diseases, expanding healthcare coverage, and advancements in portable diagnostic technologies contribute to this growth.
Key Trends
The point of care diagnostics market exhibits several significant trends shaping its landscape:
-
Glucose Self-Management
Continuous glucose monitoring is becoming standard in diabetes care. Devices like Abbott’s FreeStyle Libre enhance glycemic control and support patient adherence by integrating real-time data with therapy management. Emerging non-invasive optical sensors and wearable technologies are expected to further expand the home-care segment of point of care diagnostics.
-
CLIA-Waived Molecular POC Platforms
Rapid molecular platforms for respiratory pathogens, including SARS-CoV-2, Influenza A/B, and RSV, are improving triage workflows in clinical settings. These platforms, which deliver results within minutes, are increasingly networked with cloud-based dashboards, enhancing infection surveillance and hospital bed management.
-
Chronic and Infectious Disease Prevalence
The rising burden of chronic diseases, such as diabetes, and infectious diseases drives demand for accessible and reliable point of care diagnostics. This trend is particularly pronounced in Asia-Pacific and emerging markets, where healthcare infrastructure expansion supports wider testing adoption.
Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights:
Market Segmentation
The market is categorized based on product, platform, sample type, mode of purchase, end user, and geography. Key segments include:
By Product
-
Glucose Monitoring Kits
-
Infectious Disease Testing Kits
-
Cardiometabolic (Cardiac Marker) Testing Kits
-
Coagulation Monitoring Kits
-
Pregnancy & Fertility Testing Kits
-
Blood Gas / Electrolyte & Metabolite Testing Kits
-
Hematology Testing Kits
-
Tumor / Cancer Marker Testing Kits
-
Urinalysis Testing Kits
-
Cholesterol Test Strips
By Platform
-
Lateral Flow Assays
-
Dipsticks & Test Strips
-
Microfluidics-Based Platforms
-
Immunoassays (CLIA & FIA)
-
Molecular Diagnostics (PCR, INAAT)
By Sample Type
-
Blood
-
Urine
-
Saliva
-
Nasal / Throat Swab
-
Other Specimens (Sweat, Tear, CSF)
By Mode of Purchase
-
Over-the-Counter (OTC)
-
Prescription-Based
By End User
-
Hospitals & Clinics
-
Home-Care Settings
-
Others
By Geography
-
North America
-
South America
-
Middle east&Africa
-
Europe
-
Asia pacific
Key Players
The market includes several notable players, driving competition and product innovation. These companies focus on developing advanced testing solutions such as four-in-one molecular respiratory panels, Bluetooth-enabled glucose sensors, and handheld cardiac biomarker readers. They leverage strong R&D capabilities, regulatory approvals, and strategic partnerships to expand their presence across clinical and home-care settings. Leading firms emphasize quality, reliability, and connectivity features in their point of care diagnostics portfolio to meet evolving healthcare needs.
-
F. Hoffmann-La Roche Ltd
-
Abbott Laboratories
-
Siemens Healthineers AG
-
Becton, Dickinson and Company
-
Qiagen Inc.
Conclusion:
The point of care diagnostics market is set to experience consistent growth through 2030, supported by rising adoption in both clinical and home settings. Increasing prevalence of chronic and infectious diseases, coupled with advancements in portable diagnostic devices, ensures a steady demand for faster, more accessible testing solutions. As healthcare systems focus on reducing costs and improving patient outcomes, point of care diagnostics will continue to play a critical role in enhancing decision-making and delivering timely care. With expanding regional coverage, evolving regulatory frameworks, and innovation in user-friendly devices, the market is poised to strengthen its share globally.
Industry Related Reports:
North America Molecular Diagnostics Market : The North American Molecular Diagnostics Market is segmented based on technology, application, product, end user, and geography. Technological segments include In-Situ Hybridization, Chips and Microarrays, Mass Spectrometry (MS), Sequencing, PCR, and other technologies. Applications cover areas such as Infectious Disease, Oncology, Pharmacogenomics, and more. Product categories comprise Instruments, Reagents, and other products, while end users include Hospitals, Laboratories, and other end-user segments. Geographically, the market spans the United States, Canada, and Mexico.
Africa Molecular Diagnostics Market : The Africa Molecular Diagnostics Market report categorizes the industry across several dimensions. By technology, it includes In Situ Hybridization, Chips and Microarrays, Mass Spectrometry (MS), Sequencing, PCR, and other techniques. In terms of applications, the market covers areas such as Infectious Diseases, Oncology, Pharmacogenomics, and more. The product segment comprises Instruments, Reagents, and additional offerings, while the end-user segment encompasses Hospitals, Laboratories, and other relevant facilities. Geographically, the report focuses on key countries including South Africa, Nigeria, and others within the
Brazil In-Vitro Diagnostics Market : The Brazil In-Vitro Diagnostics Market is analyzed across multiple segments, including test type, product, usability, application, and end users. By test type, the market covers clinical chemistry, molecular diagnostics, immunodiagnostics, and other diagnostic tests. In terms of products, it includes instruments, reagents, and additional related offerings. The market also differentiates based on usability, encompassing both disposable and reusable IVD devices. Key applications span infectious diseases, diabetes, and other medical conditions, while end users include diagnostic laboratories, hospitals, clinics, and more.
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com https://www.mordorintelligence.com/
Media Contact
Company Name: Mordor Intelligence Private Limited
Contact Person: Jignesh Thakkar
Email:Send Email
Phone: +1 617-765-2493
Address:11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli
City: Hyderabad
State: Telangana 500008
Country: India
Website: https://www.mordorintelligence.com/
